Salarius Pharmaceuticals
Price & Volume
Stats
See moreOpen | $1 |
Previous Close | $1.05 |
Day Range | $0.97-$1 |
52W Range | $0.90-$5.98 |
Market Cap | $1.6M |
Shares Short | 10,411 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$15.8M |
Diluted EPS | -$5.14 |
News
See moreYahoo Finance • last year
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
Yahoo Finance • 2 years ago
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
About
CEO | Mr. David J. Arthur M.B.A. |
CFO | Mr. Mark J. Rosenblum CPA |
Address | 2450 Holcombe Boulevard, Houston, TX, United States, 77021 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
